(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
(Address of principal executive offices) | (Zip Code) |
Title of each class | Trading Symbol(s) | Name of each exchange of which registered | ||||||||||||
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Emerging growth company |
Item 2.02 | Results of Operations and Financial Condition |
Item 9.01 | Financial Statements and Exhibits |
Exhibit No. | Description | ||||
Press Release issued by Xylem Inc. on May 4, 2023. | |||||
104.0 | The cover page from Xylem Inc.'s Form 8-K, formatted in Inline XBRL. |
XYLEM INC. | ||||||||||||||
Date: May 4, 2023 | By: | /s/ Sandra E. Rowland | ||||||||||||
Sandra E. Rowland | ||||||||||||||
Senior Vice President & Chief Financial Officer (Authorized Officer of Registrant) |
For the three months ended March 31, | 2023 | 2022 | |||||||||
Revenue | $ | 1,448 | $ | 1,272 | |||||||
Cost of revenue | 902 | 805 | |||||||||
Gross profit | 546 | 467 | |||||||||
Selling, general and administrative expenses | 354 | 304 | |||||||||
Research and development expenses | 53 | 52 | |||||||||
Restructuring and asset impairment charges | 8 | — | |||||||||
Operating income | 131 | 111 | |||||||||
Interest expense | 9 | 13 | |||||||||
Other non-operating income, net | 4 | (1) | |||||||||
Gain from sale of business | — | 1 | |||||||||
Income before taxes | 126 | 98 | |||||||||
Income tax expense | 27 | 16 | |||||||||
Net income | $ | 99 | $ | 82 | |||||||
Earnings per share: | |||||||||||
Basic | $ | 0.55 | $ | 0.45 | |||||||
Diluted | $ | 0.54 | $ | 0.45 | |||||||
Weighted average number of shares: | |||||||||||
Basic | 180.4 | 180.2 | |||||||||
Diluted | 181.3 | 181.0 | |||||||||
March 31, 2023 | December 31, 2022 | ||||||||||
ASSETS | |||||||||||
Current assets: | |||||||||||
Cash and cash equivalents | $ | 837 | $ | 944 | |||||||
Receivables, less allowances for discounts, returns and credit losses of $36 and $50 in 2023 and 2022, respectively | 1,123 | 1,096 | |||||||||
Inventories | 857 | 799 | |||||||||
Prepaid and other current assets | 193 | 173 | |||||||||
Total current assets | 3,010 | 3,012 | |||||||||
Property, plant and equipment, net | 631 | 630 | |||||||||
Goodwill | 2,738 | 2,719 | |||||||||
Other intangible assets, net | 915 | 930 | |||||||||
Other non-current assets | 646 | 661 | |||||||||
Total assets | $ | 7,940 | $ | 7,952 | |||||||
LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||||||
Current liabilities: | |||||||||||
Accounts payable | $ | 710 | $ | 723 | |||||||
Accrued and other current liabilities | 784 | 867 | |||||||||
Total current liabilities | 1,494 | 1,590 | |||||||||
Long-term debt | 1,881 | 1,880 | |||||||||
Accrued post-retirement benefits | 285 | 286 | |||||||||
Deferred income tax liabilities | 215 | 222 | |||||||||
Other non-current accrued liabilities | 476 | 471 | |||||||||
Total liabilities | 4,351 | 4,449 | |||||||||
Stockholders’ equity: | |||||||||||
Common Stock – par value $0.01 per share: | |||||||||||
Authorized 750.0 shares, issued 196.5 shares and 196 shares in 2023 and 2022, respectively | 2 | 2 | |||||||||
Capital in excess of par value | 2,152 | 2,134 | |||||||||
Retained earnings | 2,331 | 2,292 | |||||||||
Treasury stock – at cost 15.9 shares and 15.8 shares in 2023 and 2022, respectively | (716) | (708) | |||||||||
Accumulated other comprehensive loss | (191) | (226) | |||||||||
Total stockholders’ equity | 3,578 | 3,494 | |||||||||
Non-controlling interests | 11 | 9 | |||||||||
Total equity | 3,589 | 3,503 | |||||||||
Total liabilities and stockholders’ equity | $ | 7,940 | $ | 7,952 |
For the three months ended March 31, | 2023 | 2022 | |||||||||
Operating Activities | |||||||||||
Net income | $ | 99 | $ | 82 | |||||||
Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||
Depreciation | 28 | 28 | |||||||||
Amortization | 32 | 30 | |||||||||
Share-based compensation | 12 | 9 | |||||||||
Restructuring and asset impairment charges | 8 | — | |||||||||
Gain from sale of business | — | (1) | |||||||||
Other, net | 3 | 3 | |||||||||
Payments for restructuring | (6) | (3) | |||||||||
Changes in assets and liabilities (net of acquisitions): | |||||||||||
Changes in receivables | (28) | (64) | |||||||||
Changes in inventories | (55) | (106) | |||||||||
Changes in accounts payable | (14) | 20 | |||||||||
Other, net | (98) | (79) | |||||||||
Net Cash – Operating activities | (19) | (81) | |||||||||
Investing Activities | |||||||||||
Capital expenditures | (49) | (49) | |||||||||
Proceeds from sale of business | — | 1 | |||||||||
Proceeds from the sale of property, plant and equipment | — | 1 | |||||||||
Cash received from investments | 2 | 4 | |||||||||
Cash received from cross-currency swaps | 11 | 7 | |||||||||
Cash paid for investments | — | (6) | |||||||||
Other, net | (1) | (1) | |||||||||
Net Cash – Investing activities | (37) | (43) | |||||||||
Financing Activities | |||||||||||
Repurchase of common stock | (8) | (51) | |||||||||
Proceeds from exercise of employee stock options | 7 | 1 | |||||||||
Dividends paid | (60) | (55) | |||||||||
Other, net | (2) | (1) | |||||||||
Net Cash – Financing activities | (63) | (106) | |||||||||
Effect of exchange rate changes on cash | 12 | (2) | |||||||||
Net change in cash and cash equivalents | (107) | (232) | |||||||||
Cash and cash equivalents at beginning of year | 944 | 1,349 | |||||||||
Cash and cash equivalents at end of period | $ | 837 | $ | 1,117 | |||||||
Supplemental disclosure of cash flow information: | |||||||||||
Cash paid during the period for: | |||||||||||
Interest | $ | 11 | $ | 23 | |||||||
Income taxes (net of refunds received) | $ | 49 | $ | 15 |
(As Reported - GAAP) | (As Adjusted - Organic) | Constant Currency | |||||||||||||||||||||||||||||||||||||||||||||||||||
(A) | (B) | (C) | (D) | (E)=B+C+D | (F) = E/A | (G) = (E - C) / A | |||||||||||||||||||||||||||||||||||||||||||||||
Orders | Orders | Change 2023 v. 2022 | % Change 2023 v. 2022 | Acquisitions/ Divestitures | FX Impact | Change Adj. 2023 v. 2022 | % Change Adj. 2023 v. 2022 | ||||||||||||||||||||||||||||||||||||||||||||||
2023 | 2022 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Quarter Ended March 31 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Xylem Inc. | 1,570 | 1,715 | (145) | (8) | % | — | 53 | (92) | (5) | % | (5) | % | |||||||||||||||||||||||||||||||||||||||||
Water Infrastructure | 639 | 660 | (21) | (3) | % | — | 29 | 8 | 1 | % | 1 | % | |||||||||||||||||||||||||||||||||||||||||
Applied Water | 483 | 505 | (22) | (4) | % | — | 18 | (4) | (1) | % | (1) | % | |||||||||||||||||||||||||||||||||||||||||
Measurement & Control Solutions | 448 | 550 | (102) | (19) | % | — | 6 | (96) | (17) | % | (17) | % | |||||||||||||||||||||||||||||||||||||||||
(As Reported - GAAP) | (As Adjusted - Organic) | Constant Currency | |||||||||||||||||||||||||||||||||||||||||||||||||||
(A) | (B) | (C) | (D) | (E) = B+C+D | (F) = E/A | (G) = (E - C) / A | |||||||||||||||||||||||||||||||||||||||||||||||
Revenue | Revenue | Change 2023 v. 2022 | % Change 2023 v. 2022 | Acquisitions / Divestitures | FX Impact | Change Adj. 2023 v. 2022 | % Change Adj. 2023 v. 2022 | ||||||||||||||||||||||||||||||||||||||||||||||
2023 | 2022 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Quarter Ended March 31 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Xylem Inc. | 1,448 | 1,272 | 176 | 14 | % | — | 45 | 221 | 17 | % | 17 | % | |||||||||||||||||||||||||||||||||||||||||
Water Infrastructure | 589 | 533 | 56 | 11 | % | — | 25 | 81 | 15 | % | 15 | % | |||||||||||||||||||||||||||||||||||||||||
Applied Water | 453 | 425 | 28 | 7 | % | — | 13 | 41 | 10 | % | 10 | % | |||||||||||||||||||||||||||||||||||||||||
Measurement & Control Solutions | 406 | 314 | 92 | 29 | % | — | 7 | 99 | 32 | % | 32 | % | |||||||||||||||||||||||||||||||||||||||||
Q1 | |||||||||||
2023 | 2022 | ||||||||||
Net Cash - Operating Activities | $ | (19) | $ | (81) | |||||||
Capital Expenditures - PP&E | (33) | (31) | |||||||||
Capital Expenditures - Software | (16) | (18) | |||||||||
Capital Expenditures | (49) | (49) | |||||||||
Cash paid in excess of tax provision for R&D law change adoption | 33 | — | |||||||||
Free Cash Flow | $ | (35) | $ | (130) | |||||||
Net Income | $ | 99 | $ | 82 | |||||||
Gain/(Loss) from sale of business | — | 1 | |||||||||
Special Charges - non-cash impairment | (2) | — | |||||||||
Net Income, excluding gain on sale of businesses, non-cash impairment charges and non-cash pension buyout settlement | $ | 101 | $ | 81 | |||||||
Operating Cash Flow Conversion | (19) | % | (99) | % | |||||||
Free Cash Flow Conversion | (35) | % | (160) | % | |||||||
Q1 | |||||||||||
2023 | 2022 | ||||||||||
Total Revenue | |||||||||||
• Total Xylem | 1,448 | 1,272 | |||||||||
• Water Infrastructure | 589 | 533 | |||||||||
• Applied Water | 453 | 425 | |||||||||
• Measurement & Control Solutions | 406 | 314 | |||||||||
Operating Income | |||||||||||
• Total Xylem | 131 | 111 | |||||||||
• Water Infrastructure | 70 | 74 | |||||||||
• Applied Water | 83 | 59 | |||||||||
• Measurement & Control Solutions | 20 | (10) | |||||||||
• Total Segments | 173 | 123 | |||||||||
Operating Margin | |||||||||||
• Total Xylem | 9.0 | % | 8.7 | % | |||||||
• Water Infrastructure | 11.9 | % | 13.9 | % | |||||||
• Applied Water | 18.3 | % | 13.9 | % | |||||||
• Measurement & Control Solutions | 4.9 | % | (3.2) | % | |||||||
• Total Segments | 11.9 | % | 9.7 | % | |||||||
Special Charges | |||||||||||
• Total Xylem | 25 | 1 | |||||||||
• Water Infrastructure | — | — | |||||||||
• Applied Water | — | — | |||||||||
• Measurement & Control Solutions | 2 | — | |||||||||
• Total Segments | 2 | — | |||||||||
Restructuring & Realignment Costs | |||||||||||
• Total Xylem | 11 | 4 | |||||||||
• Water Infrastructure | 3 | 1 | |||||||||
• Applied Water | 3 | 1 | |||||||||
• Measurement & Control Solutions | 5 | 2 | |||||||||
• Total Segments | 11 | 4 | |||||||||
Adjusted Operating Income | |||||||||||
• Total Xylem | 167 | 116 | |||||||||
• Water Infrastructure | 73 | 75 | |||||||||
• Applied Water | 86 | 60 | |||||||||
• Measurement & Control Solutions | 27 | (8) | |||||||||
• Total Segments | 186 | 127 | |||||||||
Adjusted Operating Margin | |||||||||||
• Total Xylem | 11.5 | % | 9.1 | % | |||||||
• Water Infrastructure | 12.4 | % | 14.1 | % | |||||||
• Applied Water | 19.0 | % | 14.1 | % | |||||||
• Measurement & Control Solutions | 6.7 | % | (2.5) | % | |||||||
• Total Segments | 12.8 | % | 10.0 | % | |||||||
Q1 2023 | Q1 2022 | ||||||||||||||||||||||||||||||||||
As Reported | Adjustments | Adjusted | As Reported | Adjustments | Adjusted | ||||||||||||||||||||||||||||||
Total Revenue | 1,448 | — | 1,448 | 1,272 | — | 1,272 | |||||||||||||||||||||||||||||
Operating Income | 131 | 36 | a | 167 | 111 | 5 | a | 116 | |||||||||||||||||||||||||||
Operating Margin | 9.0 | % | 11.5 | % | 8.7 | % | 9.1 | % | |||||||||||||||||||||||||||
Interest Expense | (9) | — | (9) | (13) | — | (13) | |||||||||||||||||||||||||||||
Other Non-Operating Income (Expense) | 4 | — | b | 4 | (1) | 1 | b | — | |||||||||||||||||||||||||||
Gain/(Loss) from Sale of Business | — | — | — | 1 | (1) | — | |||||||||||||||||||||||||||||
Income before Taxes | 126 | 36 | 162 | 98 | 5 | 103 | |||||||||||||||||||||||||||||
Provision for Income Taxes | (27) | (5) | c | (32) | (16) | (3) | c | (19) | |||||||||||||||||||||||||||
Net Income | 99 | 31 | 130 | 82 | 2 | 84 | |||||||||||||||||||||||||||||
Diluted Shares | 181.3 | 181.3 | 181.0 | 181.0 | |||||||||||||||||||||||||||||||
Diluted EPS | $ | 0.54 | $ | 0.18 | $ | 0.72 | $ | 0.45 | $ | 0.02 | $ | 0.47 | |||||||||||||||||||||||
Year-over-year currency translation impact on current year diluted EPS | $ | (0.04) | $ | 0.01 | $ | (0.03) | |||||||||||||||||||||||||||||
Diluted EPS at Constant Currency | $ | 0.58 | $ | 0.17 | $ | 0.75 | |||||||||||||||||||||||||||||
a | Restructuring & realignment costs of $11 million in 2023 and $4 million in 2022, as well as special charges of $25 million in 2023 including $23 million of Evoqua acquisition & integration cost and $2 million of impairment charges. 2022 special charges of $1 million for charges related to the UK pension plan exited as part of a buy-out. | ||||
b | Special non-operating charges consist of $1 million in 2022 for charges related to the UK pension plan exited as part of a buy-out. | ||||
c | Net tax impact on restructuring & realignment costs of $2 million in 2023 and $1 million in 2022; net tax impact on special charges of $3 million in 2023 and $1 million in 2022; and $1 million in 2022 of negative impact from tax related special benefits to GAAP tax. | ||||
2023 | |||||||||||||||||||||||||||||
Q1 | Q2 | Q3 | Q4 | Total | |||||||||||||||||||||||||
Net Income | 99 | 99 | |||||||||||||||||||||||||||
Net Income Margin | 6.8 | % | 6.8 | % | |||||||||||||||||||||||||
Depreciation | 28 | 28 | |||||||||||||||||||||||||||
Amortization | 32 | 32 | |||||||||||||||||||||||||||
Interest Expense (Income), net | 2 | 2 | |||||||||||||||||||||||||||
Income Tax Expense | 27 | 27 | |||||||||||||||||||||||||||
EBITDA | 188 | — | — | — | 188 | ||||||||||||||||||||||||
Share-based Compensation | 12 | 12 | |||||||||||||||||||||||||||
Restructuring & Realignment | 11 | 11 | |||||||||||||||||||||||||||
U.K. Pension Settlement | — | — | |||||||||||||||||||||||||||
Special Charges | 25 | 25 | |||||||||||||||||||||||||||
Loss/(Gain) from sale of business | — | — | |||||||||||||||||||||||||||
Adjusted EBITDA | 236 | — | — | — | 236 | ||||||||||||||||||||||||
Revenue | 1,448 | 1,448 | |||||||||||||||||||||||||||
Adjusted EBITDA Margin | 16.3 | % | 16.3 | % | |||||||||||||||||||||||||
2022 | |||||||||||||||||||||||||||||
Q1 | Q2 | Q3 | Q4 | Total | |||||||||||||||||||||||||
Net Income | 82 | 112 | 12 | 149 | 355 | ||||||||||||||||||||||||
Net Income Margin | 6.4 | % | 8.2 | % | 0.9 | % | 9.9 | % | 6.4 | % | |||||||||||||||||||
Depreciation | 28 | 28 | 27 | 28 | 111 | ||||||||||||||||||||||||
Amortization | 30 | 32 | 31 | 32 | 125 | ||||||||||||||||||||||||
Interest Expense (Income), net | 11 | 10 | 7 | 6 | 34 | ||||||||||||||||||||||||
Income Tax Expense | 16 | 24 | 5 | 40 | 85 | ||||||||||||||||||||||||
EBITDA | 167 | 206 | 82 | 255 | 710 | ||||||||||||||||||||||||
Share-based Compensation | 9 | 9 | 10 | 9 | 37 | ||||||||||||||||||||||||
Restructuring & Realignment | 4 | 8 | 6 | 16 | 34 | ||||||||||||||||||||||||
U.K. Pension Settlement | — | — | 140 | — | 140 | ||||||||||||||||||||||||
Special Charges | 2 | 3 | 14 | 1 | 20 | ||||||||||||||||||||||||
Loss/(Gain) from sale of business | (1) | — | — | — | (1) | ||||||||||||||||||||||||
Adjusted EBITDA | 181 | 226 | 252 | 281 | 940 | ||||||||||||||||||||||||
Revenue | 1,272 | 1,364 | 1,380 | 1,506 | 5,522 | ||||||||||||||||||||||||
Adjusted EBITDA Margin | 14.2 | % | 16.6 | % | 18.3 | % | 18.7 | % | 17.0 | % |
2023 | |||||||||||||||||||||||||||||
Q1 | Q2 | Q3 | Q4 | Total | |||||||||||||||||||||||||
Operating Income | 70 | 70 | |||||||||||||||||||||||||||
Operating Margin | 11.9 | % | 11.9 | % | |||||||||||||||||||||||||
Depreciation | 12 | 12 | |||||||||||||||||||||||||||
Amortization | 2 | 2 | |||||||||||||||||||||||||||
EBITDA | 84 | — | — | — | 84 | ||||||||||||||||||||||||
Share-based Compensation | 2 | 2 | |||||||||||||||||||||||||||
Restructuring & Realignment | 3 | 3 | |||||||||||||||||||||||||||
Adjusted EBITDA | 89 | — | — | — | 89 | ||||||||||||||||||||||||
Revenue | 589 | 589 | |||||||||||||||||||||||||||
Adjusted EBITDA Margin | 15.1 | % | 15.1 | % | |||||||||||||||||||||||||
2022 | |||||||||||||||||||||||||||||
Q1 | Q2 | Q3 | Q4 | Total | |||||||||||||||||||||||||
Operating Income | 74 | 108 | 104 | 132 | 418 | ||||||||||||||||||||||||
Operating Margin | 13.9 | % | 18.3 | % | 18.1 | % | 19.8 | % | 17.7 | % | |||||||||||||||||||
Depreciation | 11 | 11 | 11 | 11 | 44 | ||||||||||||||||||||||||
Amortization | 2 | 3 | 1 | 3 | 9 | ||||||||||||||||||||||||
Other non-operating expense, excluding interest income | (4) | 1 | — | (1) | (4) | ||||||||||||||||||||||||
EBITDA | 83 | 123 | 116 | 145 | 467 | ||||||||||||||||||||||||
Share-based Compensation | 1 | — | — | 1 | 2 | ||||||||||||||||||||||||
Restructuring & Realignment | 1 | 3 | 3 | 4 | 11 | ||||||||||||||||||||||||
Adjusted EBITDA | 85 | 126 | 119 | 150 | 480 | ||||||||||||||||||||||||
Revenue | 533 | 589 | 574 | 668 | 2,364 | ||||||||||||||||||||||||
Adjusted EBITDA Margin | 15.9 | % | 21.4 | % | 20.7 | % | 22.5 | % | 20.3 | % | |||||||||||||||||||
2023 | |||||||||||||||||||||||||||||
Q1 | Q2 | Q3 | Q4 | Total | |||||||||||||||||||||||||
Operating Income | 83 | 83 | |||||||||||||||||||||||||||
Operating Margin | 18.3 | % | 18.3 | % | |||||||||||||||||||||||||
Depreciation | 5 | 5 | |||||||||||||||||||||||||||
Amortization | — | — | |||||||||||||||||||||||||||
Other non-operating expense, excluding interest income | (1) | (1) | |||||||||||||||||||||||||||
EBITDA | 87 | — | — | — | 87 | ||||||||||||||||||||||||
Share-based Compensation | 1 | 1 | |||||||||||||||||||||||||||
Restructuring & Realignment | 3 | 3 | |||||||||||||||||||||||||||
Adjusted EBITDA | 91 | — | — | — | 91 | ||||||||||||||||||||||||
Revenue | 453 | 453 | |||||||||||||||||||||||||||
Adjusted EBITDA Margin | 20.1 | % | 20.1 | % | |||||||||||||||||||||||||
2022 | |||||||||||||||||||||||||||||
Q1 | Q2 | Q3 | Q4 | Total | |||||||||||||||||||||||||
Operating Income | 59 | 61 | 77 | 61 | 258 | ||||||||||||||||||||||||
Operating Margin | 13.9 | % | 14.2 | % | 16.8 | % | 13.4 | % | 14.6 | % | |||||||||||||||||||
Depreciation | 5 | 4 | 4 | 4 | 17 | ||||||||||||||||||||||||
Amortization | — | 1 | — | 1 | 2 | ||||||||||||||||||||||||
Other non-operating expense, excluding interest income | (1) | — | (1) | — | (2) | ||||||||||||||||||||||||
EBITDA | 63 | 66 | 80 | 66 | 275 | ||||||||||||||||||||||||
Share-based Compensation | 1 | 1 | 2 | — | 4 | ||||||||||||||||||||||||
Restructuring & Realignment | 1 | 2 | 1 | 9 | 13 | ||||||||||||||||||||||||
Adjusted EBITDA | 65 | 69 | 83 | 75 | 292 | ||||||||||||||||||||||||
Revenue | 425 | 429 | 458 | 455 | 1,767 | ||||||||||||||||||||||||
Adjusted EBITDA Margin | 15.3 | % | 16.1 | % | 18.1 | % | 16.5 | % | 16.5 | % |
2023 | |||||||||||||||||||||||||||||
Q1 | Q2 | Q3 | Q4 | Total | |||||||||||||||||||||||||
Operating Income | 20 | 20 | |||||||||||||||||||||||||||
Operating Margin | 4.9 | % | 4.9 | % | |||||||||||||||||||||||||
Depreciation | 7 | 7 | |||||||||||||||||||||||||||
Amortization | 27 | 27 | |||||||||||||||||||||||||||
EBITDA | 54 | — | — | — | 54 | ||||||||||||||||||||||||
Share-based Compensation | 2 | 2 | |||||||||||||||||||||||||||
Restructuring & Realignment | 5 | 5 | |||||||||||||||||||||||||||
Special Charges | 2 | 2 | |||||||||||||||||||||||||||
Adjusted EBITDA | 63 | — | — | — | 63 | ||||||||||||||||||||||||
Revenue | 406 | 406 | |||||||||||||||||||||||||||
Adjusted EBITDA Margin | 15.5 | % | 15.5 | % | |||||||||||||||||||||||||
2022 | |||||||||||||||||||||||||||||
Q1 | Q2 | Q3 | Q4 | Total | |||||||||||||||||||||||||
Operating Income | (10) | (5) | (2) | 19 | 2 | ||||||||||||||||||||||||
Operating Margin | (3.2) | % | (1.4) | % | (0.6) | % | 5.0 | % | 0.1 | % | |||||||||||||||||||
(Loss)/Gain from Sale of Business | 1 | — | — | — | 1 | ||||||||||||||||||||||||
Depreciation | 9 | 8 | 8 | 8 | 33 | ||||||||||||||||||||||||
Amortization | 25 | 26 | 27 | 26 | 104 | ||||||||||||||||||||||||
Other non-operating expense, excluding interest income | — | (1) | (1) | — | (2) | ||||||||||||||||||||||||
EBITDA | 25 | 28 | 32 | 53 | 138 | ||||||||||||||||||||||||
Share-based Compensation | 1 | 2 | 2 | 1 | 6 | ||||||||||||||||||||||||
Restructuring & Realignment | 2 | 3 | 2 | 3 | 10 | ||||||||||||||||||||||||
Special Charges | — | 1 | 12 | 1 | 14 | ||||||||||||||||||||||||
Loss/(Gain) from sale of business | (1) | — | — | — | (1) | ||||||||||||||||||||||||
Adjusted EBITDA | 27 | 34 | 48 | 58 | 167 | ||||||||||||||||||||||||
Revenue | 314 | 346 | 348 | 383 | 1,391 | ||||||||||||||||||||||||
Adjusted EBITDA Margin | 8.6 | % | 9.8 | % | 13.8 | % | 15.1 | % | 12.0 | % |
Cover Page |
May 04, 2023 |
---|---|
Cover [Abstract] | |
Document Type | 8-K |
Document Period End Date | May 04, 2023 |
Entity Registrant Name | XYLEM INC. |
Entity Incorporation, State or Country Code | IN |
Entity File Number | 001-35229 |
Entity Tax Identification Number | 45-2080495 |
Entity Address, City or Town | Washington |
Entity Address, State or Province | DC |
Entity Address, Postal Zip Code | 20003 |
City Area Code | 202 |
Local Phone Number | 869-9150 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Entity Emerging Growth Company | false |
Entity Central Index Key | 0001524472 |
Amendment Flag | false |
Entity Address, Address Line One | 301 Water Street SE |
Title of 12(b) Security | Common Stock, par value $0.01 per share |
Trading Symbol | XYL |
Security Exchange Name | NYSE |
F!.M:R)'O6 MCVU0OZS9*=0]G%B-3T.[!^UU:=3IM4&=.U'H?S]%?2DZ
&OJ^H;NG'-;L!'KTOXA2SAS2 ?9-9AT^ZBP^:7SF%W
MZR74EW&6CTE2H")%1\SCKI0__P D>2?**,V0J.[0-UO?B=1'1< X_>,L+$*H
MN#GQ C"J&-KS"@3)HBDK6]\-;G1P8@_9*,T*M+/\S@B8'2PO$#OC3M.L3&;T
M3?TQ1,67TOAISDVB"IH[W*#Z25&G\(L00YL!+R90,A6F0*O DM]+MDRMP==O
MFN+)$O&(@$V3"8HI8\$535&0,155TQ!E9H)I;I$I4MZ6?NP;A 'EL+3(P,C,P-3 T7W!R92YX;6S56EMOV\82?O>O4'5>SUA[Y2Z-V(6/
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MKUZT.^>"2R4VZH11D7?+38X;)J](6+T+^!6>W@#Q2IJ_D,%Q<]"&:QJ 7]>NNHDK29E;3&EF=\W43ITB>*AT'AP_
M? 6XPDVILH6O;!J$,7/(7620S^$M]5U;&E-S
MSW<44[ZNRUD8,M]^X!N\8_Z,:8BNDY?DH^MYX+^?ZS7B$,Q/41 Z+(03Y-%I
MQ,[2'\[3$HBN+V85+YTO;Y1K"&L!#-BW?'Q^[SKQ^&PP,+JGYL\_S<,GR8?E
M4]. 5:ZJ6LFSEM%M%3]N&6;QJX],VS7ZK>(W'YOU\6?==J?6:^T;G 6PM
M,C R,S U,#1?<')E+GAM;%!+ 0(4 Q0 ( )8XI%8K,_NS$F4 !X("@ 4
M " ? I !X>6PP-3 T,C R,V5X.3DQ+FAT;5!+!08
..!0 % $(! TCP !
end
C$99.LI"'F3MIA/DLB@]Y]XFGLA]4L@0_D)^&'&=/
MIW&-RDD 'G63"5BD3% \3Q4,695![]1D60$(%7WZ6Z G<)W@K;#=#W5/4:%"
M&1&P$9;.\VXIFDJJ>$6MM'T"A;3S6/7J=<$C#D3I%7;L,!T@Z7.VXKVV,!
MR1&+F,>?L$S24EJ,B5:>_E*U2B=][B>L8CP8UTWOENUD%WX>Q'BYFDT+FXN\O3Q
M\*]/7?WL\V9Z95DFR+ZCVRD3W(R1H4!\F,8ZB<[)-*_4[O,-M)MX]QH'W]Q>N4
M
0!@
M.C]6X'OA$":-)A0XX?
M*:R6+15.G\([+A:;)358L>=R\#DB_CF#$R&*60.CAC:R\ F?,2=9%$A^>">Q
MR@".;IAX+0(NC -'U&A:G%K^<;XQ8>'#);B4&$=\"3"!()0)<'2@:\&>$F[,
MW^1Y4G>^;:O
X15FD:+=60I!VK5&_!NHQ$P#XG8-^(OJCORC0;SW^6?JF.
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MR!PW)E[ U: (G:_;#$6=+=M6XQXQ+AIZ!#7
MMX,)(S']46-'FX7YV:@P/<*6K(-V(JNQNI23GYTH4'OR8"E-??G,J=/#9&W4
MF0KQT^EALO:ACJ)TJN])3]*W+$4!GVJTNQKZG73)8JX':17PN$:G4_;:KB*9
MO1@(/;)*>1,']O=QX'$JB-+48RC2$C_LW.K]Z8B-0KG'FZP02W._NPPFD\ G
M@FJ(H!?SG$QI2.ZH-V/D9
2>7+9*/IR.681:_^LBT7:/?*G[SL5D??]9M=YYAK9:YW:R'7VO?L 8]7.O>USHP3LV!
M)FOM&V97E[/5-SH=/%O[7ZM@V_V-IGWB#N[39>/,M;$YM_*D #[,W;7^9G5*
M+R(R5T*:(M%Y[>9MW> QCPTT4Y5L+R!9'UKVWN8A%=C-P)7JIROW'P^N;F^X
MVD2)7K%O]G'^,W=]]]6?^)#S*'8V"TKO7FQR#A%N:W#[13FXE6"2]4+5I7*H
MT@-N[Q%N6\'MZO6K%Z?F^2__N/S'>X3@-A#\]341("17PM5]L5]5L4* ^I "
MZN2*:]:7\!N'%UD&V/[T,*V L^+5?6XK P&@' N92C-:EEM
#JY@N1L#$"#PV>O_C7)N3:MPWR*?";
M'RXNOI"OS Y\V_5<"J@N38.'WL(G%I-+&HU)DWR>LI OVK\E%S8G:$ZJ_#-W
MD4%^#1F3@W[U@GOEMW3RDGQT/0_*_+U>6RSGQ,!9%V
J^:B&(/7X%([41D)H[YG&A)AW9
KN
M"[&@(;6H@L&_^-
_!9$T>M7+SJ]\P^4*]2C,)B0&^HQ$HS(+[.(OQ!M=RL]!QA'I_C-+FN4
MI?=\M.MBF6N(H)UNTR":$$V()D23;F@ZHE2J@VMQYY9,^FKXQ^DTAB;8Q@CJ
M(X(008@@1%!U$=0N>XL>J\$>MKV9BHKSAM'Z"M5^K2B&REYQ1@P=&D,5:MM:
M40SA&5(<0V9KRU8EZ,+9,#LL'K.0^('?#.9Y8NP']"5A#?Z#[W2HE#HV\
M0RMIB"!$$"((65QU$;1E=7;T96$7Z_)W +:TCC6UEC1$T):&+B((3Q B"$^0
M#@@RRY:+P"PF[ C_S)=1T>HY-!- !"F.(/3LJ(XA1)#B""J;KHVNG5**#E0>
M$H6'3J#RT&M9>BA*2@\-JU9Z:/^9I6CY:)%9BFA"-"&:$$V:HNE($JD.GIZ5
MWL)[ZF.O?V)9Z